Skip to content
Announcement:

Join us at this webinar you will hear from our 3 panelists discuss regulatory, technology and scientific perspectives to gain insights, into accelerating your compound through the clinical development pipeline with a focus on retina.

Human iPSC differentiation to retinal organoids in response to IGF1 and BMP4 activation is line- & method-dependent

Published

30th December, 2019

Published by

Valeria Chichagova, Gerrit Hilgen, Ali Ghareeb, Maria Georgiou, Madeleine Carter, Evelyne Sernagor, Majlinda Lako, Lyle Armstrong

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Click the button below to view the article.

View Article

Get our latest updates straight to your inbox